Tagged with HIV

Gilead Switzerland’s Stuart Head on Access, MFN & Valuing Innovation
Xia JIN – Co-Founder & CEO, Immuno Cure
Jimmy Chang – Chairman & CEO, TaiMed Biologics
Cathy Su – General Manager, Gilead Sciences Taiwan, Hong Kong/Macau & Singapore
Arturo de la Rosa – VP Latin America, Gilead
The End of the Road for an HIV Vaccine?
MEA: Egypt’s Latest Biomanufacturing Push; Hikma Targets Obesity; HIV and TB Resurgence
HIV: Public Policy Progress
HIV: Shifting the Treatment Paradigm
HIV: Revolutionised Market Access
Xia JIN – CEO & Tom LAU – Director of Corporate Finance, Immuno Cure
Linda-Gail Bekker – CEO, Desmond Tutu Health Foundation
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here